BioCentury
ARTICLE | Clinical News

Amikacin Fosfomycin Inhalation System regulatory update

January 20, 2014 8:00 AM UTC

FDA granted Qualified Infectious Disease Product (QIDP) designation to Amikacin Fosfomycin Inhalation System for adjunctive treatment of mechanically ventilated patients with bacterial pneumonia. The ...